Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
But.....you posted PPS does not matter because
You have " the golden ticket " in 22 months.
Why now " let's go back up "
Could the DEA have derailed this thing again ??
Did the " Rat " mislead investors again ??
When will the sell off end ??
Darn penny stocks,
Weird, I thought once ELTP closed the gap that the King said would never close, it would have a decent bounce back up
Too soon?
Enough playing with the price - let's go back up
The gap has been hit. Yippee. King said it would never happened. He should never be called King by anyone here.
THX, now they can show the FDA/DEA proof of sales, so they can order more API
From my limited point of view working as a semi-retired part time floater pharmacist: Adderall generic, thanks to Elite and a few others, is mostly available. Concerta generic by Trigen occasionally comes in when ordered, but is mostly out of stock. Vyvanse generic seems to be on terminal backorder. Just some anecdotal info…… GLTA
just noticed this from the Elite page
Commercial Operation Inquiries
https://elitepharma.com/contact/
Maybe it's old
Or they have been getting a lot of calls ?
No end in sight
https://abc7.com/adhd-drug-shortage-adderall-ritalin-coping-tips/14697865/
Can't get that new plant built fast enough.
Yes, continued expected growth is exactly what I said. In the event happens that the company isn’t sold, you still want to plan longer term.
Good morning. Today will be a great day Happy Passover. God bless. Cheers.
Good grief! They want a 5 year lease because they see themselves needing the extra space for the long-term. The reason the question was stupid because 'bubba' asked why would Elite sign a 5 year lease agreement if they can see selling the company in 2 years. If the lease was only for 2 years it would make the company less attractive to a prospective buyer because the new owner would have to figure out how to solve the space problem again and that space is a sweet solution for Elite (sweet = economic and convenient) . In most (maybe all...?) states the new owner has to honor the previous owners lease agreements made with the original owner or management, unless the lease agreement specifically states that the lease will terminate in such case. In Elite's case this is a benefit. The new owner will need the space just like Elite. So Elite having the space wrapped up for 5 years will facilitate a sale.
To position themselves for growth from operation perspective. Buyout valuation will be based on DCF including future growth accounting for any caped needs to continue the growth. Since we care nearing max storage capacity with current building it makes sense to both expand storage and mfg bandwidth to plan for near term growth.
We are waiting on drug trials for one of the monsters too. A lot of stuff.
It's these things that make it apparent that he has no idea why he is on the msg board. He is literally on the job
So sums that a Moron like you couldn’t answer it
PPS is not going much of anywhere until JUNE 27, 2024 unless manipulated down more OR we get news of a FDA approval... until then we just watch the circus animals!
I do expect an earnings surprise to the UP side when ELTP shares their annual report at the end of JUNE.
Small drug approvals could come at anytime.
Might be one of the dumbest questions I have seen on here in 6 years, and that is saying a lot.
Need room for $5.1 Billion Vyvance
$720 million OxyContin
and one more NeedleMover
I agree ................
There has been a lot of eggs left to rot in this basket over the years,
IB_🤴🏻
.12 .11 .02 load up shares…..$2.00 rich
Why would they lease a new location through 2028 if they are selling the company in 2 years?? Hmmmm
Never count your Chickens before they hatch.
Well that is even BETTER!!!
Turn it into $1000 to $2000
GLTY
Dude, I was there long ago.......... were you EVER~?
Yes, I was trying to recall which building it was when I attended the SHM way back when.
Images did not help my recall....... "King".
"Up the hill me boys, up the hill~!" LMAO~!
$DBMM baby~!
PE ratio is stupid low. Corrupt markets will do that though.
$ELTP baby~!
What about if its a trillion dollar drug?
GO ELTP
Nothing would be expected here for several months, assuming no CRL.
Did you say "IF" ????????????????????
LoL LoL,
IB_🤴🏻
Still sinking, huh? If you could see my face right now it is very handsome and not surprised.
Did you change your mind about taking it lower ............................
Seems to be the case,
IB_🤴🏻
If positive news hits about the Billion dollar drug we will be back to the top in no time.
I HAVE the winning ticket
lol lol lol on the way to the bank...
I sure hope youre right
hate to see ELTP fall any further. Maybe the .123 gap fill can support it some
catalyst:
X 1. Cash Flow Positive Status - 5 years
X 2. Purchase building housing their cGMP registered facility for research, development, manufacturing and packaging of pharmaceutical products.
X 3. Adderall IR $335 Million Approved and Launched
X 4. Adderall XR $1.56 Billion Approved and Launched
X 5. Double digit quarterly revenues in millions
X 6. In house marketing and distribution: Kirko Kirkov, Doug Plassche and their teams
X 7. Prasco/Burel Adderall agreement starting January 1st 2024
X 8. First shipment Adderall XR to PRASCO Dec 2023
X 9. DEA increases manufacturing quotas for Adderall & Vyvance
X 10. Generic Vyvanse - $5.1 BILLION - FDA submission Dec 2023
X 11. FDA Acceptance of Generic OxyContin Sept 2023
__12. Dopamine Agonist (probably Requip XL or Mirapex ER). $12 Million
X 13. Vigabatrin Approval $233 Million
X 14. Pyros Settle Vigabatrin -VigPoder trade mark challenge then LAUNCH
__15. Generic Methotrexate Approval- Antimetabolite $42 Million
__16. $50 million in yearly revenues
X 17. Lease additional manufacturing space and storage vault for new Needle Mover ANDAs - Jan 2024
__18. Generate revenues over $20 million/quarter
__19. Generic OxyContin Approval - FIRST TO FILE Aug 17, 2023 $720 Million
__20. Prevail over Purdue in Generic OxyContin infringement suit - 6 month stay
__21. European distribution - Dexcel partnership approval by Israeli Health
__22. Full ownership of Adderall IR $ 335 Million
__23. Full ownership of Adderall XR $ 1.56 Billion
__24. Generic Concerta- $1.2 BILLION FDA submission
__25. $100 million in yearly revenue
__26. Generic Vyvanse Approval and Launch
__27. $200 million in yearly revenue
__28. Deep pocket partner for SequestOx
__29. Patented Unique ADF (w/o naltrexone)-- NDA
__30. Mikah ANDA (s)
__31. Undisclosed ANDAs/NDAs
__32. DollarLand PPS
__33. Uplist to the NASDAQ Exchange
__34. ELTP Elite Pharmaceutical Buyout - less than 2 1/2 years from Feb 2024
__35. Vegas Baby !!!!!!!
X 36. PE below 8.
I have the winning ticket for 22 months from now.
I won $100 in the lottery last week.
Should I roll the whole thing into ELTP shares or dollar cost average?
DEC 5 .1291
DEC 23 ..127
MAR 12 .1293
TODAY .124
Actually. I think we hit the gap today. This is a good thing. The king said it would never happened. Where is he know?
Still no gap. I wonder if this is good enough. .124.
Clearing a good chunk of change this week buying more
Im taking advantage of any dips
$$$$$$$$$$$$$$$$$$$$$$
Massive BuyOut 22 months
GLTA
Something needs to be done to stop ELTPs collapse into the 12s and going even lower
Has your $750 cleared yet so you can load the boat again this week?
Hope so!
GO ELTP!!
You beat me - long for 13 years here...
This stock is the first stock where I see longs ask for the price to go down so they can buy more of it lol
We are partnering with Goatland for a better future lol
Calm before the storm. I’m long for 15 years with elite. It’s been a long ride. bring back ART tech. Cheers.
Followers
|
1065
|
Posters
|
|
Posts (Today)
|
46
|
Posts (Total)
|
415064
|
Created
|
03/24/09
|
Type
|
Free
|
Moderators mrwrn2010 NASDAQ2020 IB_ namtae |
Senior Moderator: IB_
Posted: 7/02/2024
________________________________________________________________________________________________________________
Elite Pharmaceuticals, Inc. |
Website | Location | Employees | Facility | CEO |
www.elitepharma.com | Northvale, New Jersey | 64 | 85,000 sq ft | Nasrat Hakim |
Products & Pipeline | ||||
Drug | Market Size | Status | Competitors | Marketed By |
Adderall IR | 389.8 M | On Market | 15 | Elite Dexcel |
Adderall XR | 1.56 B | On Market | 10 | Elite Prasco |
Dantrolene | 6.3 M | On Market | 2 | Elite |
Isradipine | 5.5 M | On Market | 1 | Elite |
Loxapine | 5 M | On Market | 2 | Elite |
Phendimetrazine | 4.5 M | On Market | 4 | Elite |
Trimipramine | 2 M | On Market | 1 | Elite |
Naltrexone | 16 M | On Market | 5 | Precision Dose |
Phentermine Capsules | 7.5 M | On Market | 6 | Precision Dose |
Phentermine Tablets | 40 M | On Market | 8 | Precision Dose |
Vigabatrin | 233.7 M | On Market | 13 | Pyros |
Doxycycline | 85 M | Approved (Discontinued) | 9 | ---------- |
Tylenol with Codeine | 47 M | On Market | 5 | Elite |
Dopamine Agonist | 12 M | Filed with FDA - 22 Dec 2022 | ---------- | ---------- |
Methotrexate | 63.4M | On Market | 8 | Elite |
Percocet | 500 M | Approved in Launch Queue | 14 | ---------- |
Norco | 477 M | Approved in Launch Queue | 12 | ---------- |
Methadone | 30 M | Approved in Launch Queue | 8 | ---------- |
OxyContin | 720 M | Filed with FDA - 17 Aug 2023 | 4 | ---------- |
Vyvanse | $4.30 B | Approved in Launch Queue | 11 | ---------- |
Concerta | 1.16 B | In Development (Final Stages) | 8 | ---------- |
Financials | ||||
Fiscal Year | Revenue | Change | Net Income | Change |
2019 | 7,568,508 | ---------- | (9,279,321) | ---------- |
2020 | 17,994,639 | +137.76% | (2,240,351) | +75.86% |
2021 | 25,380,749 | +41.05% | 5,088,421 | +327.13% |
2022 | 32,262,117 | +27.11% | 8,898,245 | +74.87% |
2023 | 34,155,114 | +5.87% | 3,561,846 | -59.97% |
2024 | 56,625,128 | +65.79% | 20,108,631 | +464.56% |
2025 Q-1 | 18,803,000 | +109.39% | 3,864,056 | +144.00% |
2025 Q-2 | 18,880,000 | +33.00% | 3,500,000 | +84.00% |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |